If you need more lookups,
subscriptions start at $34 USD/month.
Henry Wu Location
Edison, NJ, US
Henry Wu Work
2022 -now Chief Development Officer @ Lynk Pharmaceuticals
2022 -now Venture Partner @ Wisdomont Capital
2017 -2022 CEO @
2010 -2016 CEO, COO, VP @
2005 -2010 Independent Consultant @ Innotics Inc.
2004 -2005 Consultant @
2003 -2004 Consultant @
2002 -2003 Consultant @
2000 -2002 Senior Programmer II @
1999 -2000 Statistical Programmer @ Kendle
Henry Wu Education
National Defense Medical Center
Masters (Pharmacology)
1996-1998
Taipei Medical University
Bachelors (Pharmacy)
1992-1996
Henry Wu Skills
Clinical Development
21 CFR Part 11
Clinical Trials
Pharmaceutical Industry
Biostatistics
EDC
CRO
Drug Development
Oncology
GCP
Clinical Research
FDA
SAS programming
Pharmacovigilance
Statistical Programming
Clinical Data Management
Validation
Regulatory Submissions
SAS
CTMS
Neurology
CDISC
Medical Writing
Infectious Diseases
Protocol
Therapeutic Areas
Regulatory Affairs
Data Management
Sop
Biotechnology
Drug Discovery
Vaccines
Diabetes
Cardiology
Oracle Clinical
Lifesciences
Clinical Study Design
Computer System Validation
IND
Leadership
Sales
Java
Project Management
Statistics
GMP
eCTD
Regulatory Requirements
Generic Programming
Pharmaceutics
Henry Wu Summary
Henry Wu, based in Edison, NJ, US, is currently a Chief Development Officer at Lynk Pharmaceuticals. Henry Wu brings experience from previous roles at Wisdomont Capital, CR Medicon Pharmaceutical Technology CO., Ltd., FMD K&L and Innotics Inc.. Henry Wu holds a 1996 - 1998 Masters in Pharmacology @ National Defense Medical Center. With a robust skill set that includes Clinical Development, 21 CFR Part 11, Clinical Trials, Pharmaceutical Industry, Biostatistics and more. Henry Wu has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Henry Wu?
Find contact details for 700 million professionals.